Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Your search for Sando-K returned no results
Showing 1 result for sandoz-k

  1. Selinexor with bortezomib and low-dose dexamethasone for treating relapsed refractory multiple myeloma [ID3797]

    In development [GID-TA10646] Expected publication date: 15 May 2024